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Introduction
• Kawasaki disease (KD) and Multisystem
Inflammatory Syndrome in Children (MIS-C)
associated with COVID-19 are both inflammatory
disease processes with significant clinical overlap,
making differentiation challenging.

Results
Patient Inclusion Flowchart

• KD is an acute systemic vasculitis often with
coronary artery involvement. MIS-C is a late
manifestation of COVID-19 often with myocardial
involvement.
• Both are clinical diagnoses, and there is no definitive
diagnostic test specific for either disease process.

Coronary Artery Involvement
• Maximum coronary artery Z-score was greater for KD
vs MIS-C (median 1.36 vs 1.23; p<0.05).
• Higher baseline log(NT-pro BNP) was not associated
with maximum coronary artery Z score (p=0.36) but
with maximum coronary artery Z-score >2 (p=0.02).
• Baseline log(Troponin I) was not associated with
higher maximum coronary artery Z-score (p=0.23) or
maximum Z-score >2 (p=0.72).
Independent Factors Associated with
Cardiac Biomarkers

Phenotypic Overlap

Objectives

Distribution map, International Kawasaki Disease Registry

Prediction of MIS-C vs. KD
• Baseline troponin I >10 ug/L (c-statistic 0.65) predicted MIS-C vs
KD with a sensitivity of 58% and specificity of 77%.
• Troponin I >20 ug/L predicted MIS-C vs KD with a
sensitivity of 44% and specificity of 89%.
• Baseline NT-pro BNP >500 ng/L (c-statistic 0.71) predicted MISC vs KD with a sensitivity of 74% and specificity of 54%.
• NT-pro BNP >1000 ng/L: 61%, 72%, respectively.
• NT-pro BNP >1500 ng/L: 56%, 77%, respectively.
• C-statistic: 0.74 with both biomarkers together.
• C-statistic: 0.78 with both biomarkers at peak.

• To determine how cardiac biomarkers might
differentiate MIS-C from KD.

• To determine the association of cardiac biomarkers
with clinical features and outcomes for MIS-C and
KD.

Distribution of Cardiac Biomarkers by Diagnosis

Methods
• Study period: January 2020 to July 2022.
• Population: Contemporaneous KD and MIS-C patients
from 42 sites in 8 countries.
• MIS-C defined by site and confirmed by CDC criteria
with documented
High-Risk
BP: evidence of prior COVID-19 infection.
• Mid-Risk
KD defined
by site and confirmed by AHA guideline
BP:
criteria with documented evidence of no prior COVID-19
Mid-Risk
infection. BP:
• Included patients had at least one measurement of NTpro BNP or troponin I and echocardiogram.
• Normalizing logarithmic transformation was applied to
biomarker levels.
• Multiple imputation of missing values of factors was
performed for multivariable analyses.
• Multivariable general linear regression models for
associated factors with cardiac biomarkers were
adjusted for diagnosis, age, and creatinine at
presentation.
• ROC curves were used to determine biomarker cut
points differentiating MIS-C vs KD.

Questions? Contact mmwalton@cmh.edu

Biomarkers and Outcomes

Conclusions

Adjusted for diagnosis, age and creatinine

• Higher log(NT-pro BNP) and log(Troponin I) associated
with shock at presentation (p<0.001, p<0.001).
• Higher log(NT-pro BNP) and log(Troponin I) associated
with ICU admission (p=0.003, p<0.001).
• Higher log(NT-pro BNP), but not log(Troponin I), was
associated with longer LOS (p<0.001, p=0.23).
Myocardial Involvement
• Left ventricular ejection fraction (LVEF) was lower for
MIS-C vs KD (median 56% vs 63%; p <0.001).
• Higher baseline log(NT-pro BNP) was associated with
lower LVEF (p<0.001) and LVEF<55% (p<0.001).
• Higher baseline log(Troponin I) was associated with
lower LVEF (p=0.03) and LVEF<55% (p=0.03).

• Higher baseline levels of troponin I and NT-pro BNP are predictive of MIS-C versus KD with reasonable
sensitivity and specificity.
• Higher baseline cardiac biomarker levels are associated with an increased likelihood of shock and ICU
admission. Higher NT-pro BNP was associated with increased hospital length of stay.
• Both biomarkers were independently associated with markers of inflammation, with troponin I also
associated with greater hepatic involvement.
• Lower LVEF, more pronounced for MIS-C, is associated with higher NT-pro BNP and troponin I levels.
• Increased likelihood and higher magnitude of coronary artery involvement, greater for KD, are not
associated with levels of either cardiac biomarker.
• These findings indicate that cardiac biomarkers may be helpful in differentiating MIS-C vs KD, and may be
prognostic of clinical severity.
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